PHOX

Aura AI Photonics ETF

Bearish Trend

Near 52W Low

$24.71+$0.50 (+2.07%)

Loading Chart...

Institutional Signal // Day Trade Edge:Neutral / No Active Setup Today

Scan Active Universe on Day Trade Edge

Key Statistics

Market Cap—

Forward P/E—

EPS (TTM)$0.45

52-Week Return-0.04%

50-Day Moving Avg$24.99

200-Day Moving Avg$24.99

Volume Today2.07K

Avg Volume6.43K

Day Range$24.61 – $24.92

52-Week Range$22.94 – $29.61

Open Price$24.86

Previous Close$24.21

Company Profile

Description

Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in Optical and Photonic Companies. It is non-diversified.

SEC Filings

EDGAR Filings

Exchange Listing

Nasdaq.com

Company Profile

Description

Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in Optical and Photonic Companies. It is non-diversified.

SEC Filings

EDGAR Filings

Exchange Listing

Nasdaq.com

PHOX

Key Statistics

Company Profile

Company Profile

Recent News

PHOX Targets the AI Infrastructure Bottleneck Most Investors Miss

PHOX ETF Investors: Watch These 4 Earnings Dates Before Year-End

Aura Launches PHOX, a New ETF Tracking AI Photonics Companies at 0.60% Expense Ratio

Aura ETFs, Founded by ETF Industry Leader Rob Oliver, Launches AI Photonics ETF (PHOX)

Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Recent News

Company Profile

Recent News

PHOX Targets the AI Infrastructure Bottleneck Most Investors Miss

PHOX ETF Investors: Watch These 4 Earnings Dates Before Year-End

Aura Launches PHOX, a New ETF Tracking AI Photonics Companies at 0.60% Expense Ratio

Aura ETFs, Founded by ETF Industry Leader Rob Oliver, Launches AI Photonics ETF (PHOX)

Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)